Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Clinical & Translational Immunology
- Vol. 10 (4) , e1271
Abstract
Objectives: Emerging evidence of dysregulation of the myeloid cell compartment urges investigations on neutrophil characteristics in coronavirus disease 2019 (COVID‐19). We isolated neutrophils from the blood of COVID‐19 patients receiving general ward care and from patients hospitalised at intensive care units (ICUs) to explore the kinetics of circulating neutrophils and factors important for neutrophil migration and activation.Methods: Multicolour flow cytometry was exploited for the analysis of neutrophil differentiation and activation markers. Multiplex and ELISA technologies were used for the quantification of protease, protease inhibitor, chemokine and cytokine concentrations in plasma. Neutrophil polarisation responses were evaluated microscopically. Gelatinolytic and metalloproteinase activity in plasma was determined using a fluorogenic substrate. Co‐culturing healthy donor neutrophils with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) allowed us to investigate viral replication in neutrophils.Results: Upon ICU admission, patients displayed high plasma concentrations of granulocyte–colony‐stimulating factor (G‐CSF) and the chemokine CXCL8, accompanied by emergency myelopoiesis as illustrated by high levels of circulating CD10−, immature neutrophils with reduced CXCR2 and C5aR expression. Neutrophil elastase and non‐metalloproteinase‐derived gelatinolytic activity were increased in plasma from ICU patients. Significantly higher levels of circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) in patients at ICU admission yielded decreased total MMP proteolytic activity in blood. COVID‐19 neutrophils were hyper‐responsive to CXCL8 and CXCL12 in shape change assays. Finally, SARS‐CoV‐2 failed to replicate inside human neutrophils.Conclusion: Our study provides detailed insights into the kinetics of neutrophil phenotype and function in severe COVID‐19 patients, and supports the concept of an increased neutrophil activation state in the circulation.Keywords
Funding Information
- Financiadora de Estudos e Projetos (01.20.0003.00)
- Fonds Wetenschappelijk Onderzoek (G0F7519N, PhD fellowship to Lore Vanderbeke, PhD fellowship to Marfa Blanter, PhD fellowship to Seppe Cambier, postdoc fellowship to Jennifer Vandooren)
- Onderzoeksraad, KU Leuven (C16/17/010)
- KU Leuven (KOOR grant ESA‐COVID2‐O2010)
This publication has 51 references indexed in Scilit:
- Emergency granulopoiesisNature Reviews Immunology, 2014
- The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseasesExpert Review of Clinical Immunology, 2014
- Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 PathwayPLOS Pathogens, 2014
- Neutrophils in the activation and regulation of innate and adaptive immunityNature Reviews Immunology, 2011
- Chemokine receptors intracellular traffickingPharmacology & Therapeutics, 2010
- Identification of CD63 as a tissue inhibitor of metalloproteinase‐1 interacting cell surface proteinThe EMBO Journal, 2006
- Lineage-Specific Hematopoietic Growth FactorsNew England Journal of Medicine, 2006
- Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasisBlood, 2004
- Proteolytic Enzyme Levels Are Increased During Granulocyte Colony-Stimulating Factor-Induced Hematopoietic Stem Cell Mobilization in Human Donors but Do Not Predict the Number of Mobilized Stem CellsJournal of Hematotherapy & Stem Cell Research, 2002
- Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine FamilyJournal of Biological Chemistry, 2001